https://live-biotherapeuti...

Some of the gut bacteria will soon be expected to emerge as potential sources of novel disease therapeutics. These indicate that NGPs may not be purely developed as traditional probiotics only as foods or dietary supplements but may also be defined as organisms developed for pharmaceutical application.